The purpose of this paper was to determine the differences in peptide content between serum and plasma specimens and to evaluate the effects of anticoagulant, protease inhibitors, and storage of specimens at room temperature.
Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma.
Yi J, Kim C, Gelfand CA
Purpose
Conclusion
Serum peptide profiles contained more peaks, and higher peaks than plasma, regardless of anticoagulant. Serum peak intensity decreased for the most abundant peaks with time at room temperature, but for lower abundance peaks, intensity increased, and new peaks appeared with time at room temperature. Plasma peptide peaks also changed with time at room temperature, although, not as extensively as serum profiles, and the changes varied with each anticoagulant. The inclusion of protease inhibitor cocktail with specimens collected in EDTA tubes moderated the changes observed in EDTA-plasma with time at room temperature.
Studies (1)
Purpose
The purpose of this study was to determine the differences in peptide content between serum and plasma specimens and to evaluate the effects of anticoagulant, protease inhibitors, and storage of specimens at room temperature.
Summary of Findings
Serum peptide profiles contained 137 peaks, whereas heparin-plasma, EDTA-plasma, and citrate-plasma profiles included 73, 66, and 57 peaks, respectively. Serum peak intensities were higher than plasma peak intensities, regardless of anticoagulant. However, serum peak intensity decreased for the most abundant peaks with time at room temperature, but for lower abundance peaks, intensity increased, and new peaks appeared with time at room temperature, suggesting proteolysis. Plasma peptide peaks also changed with time at room temperature although, not as extensively as serum profiles did and the changes varied with each anticoagulant. The inclusion of protease inhibitor cocktail with specimens collected in EDTA tubes resulted in lower peak intensities and fewer peaks in the 840 to 1200 mass-to-charge ratio range and higher peak intensities in the 1500 to 1880 mass-to-charge ratio range at time 0. Protease inhibitors also moderated the changes observed in EDTA-plasma with time at room temperature.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
FrozenNone (Fresh)Diagnoses
NormalPlatforms
PeptideMALDI-TOF MSProteinMALDI-TOF MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Lithium heparinNonePotassium EDTASodium citrateBiospecimen Aliquots and Components Blood and blood products PlasmaSerumBiospecimen Preservation Type of fixation/preservation FrozenNone (fresh)Storage Storage temperature -80 degrees CStorage Time at room temperature 0 min2 h24 h30 min4 h48 h5 h72 hAnalyte Extraction and Purification Protease inhibitor CocktailNo protease inhibitor added